Joseph Caprioli1, Julie H Kim2, David S Friedman3, Tina Kiang2, Marlene R Moster4, Richard K Parrish5, Eva M Rorer2, Thomas Samuelson6, Michelle E Tarver2, Kuldev Singh7, Malvina B Eydelman8. 1. Department of Ophthalmology, Jules Stein Eye Institute, UCLA David Geffen School of Medicine, Los Angeles, California. 2. Office of Device Evaluation, Centers for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland. 3. Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland. 4. Department of Ophthalmology, Wills Eye Institute, Jefferson Medical College, Philadelphia, Pennsylvania. 5. Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miami, Florida. 6. Minnesota Eye Consultants, Minneapolis, Minnesota. 7. Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California. 8. Office of Device Evaluation, Centers for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland. Electronic address: malvina.eydelman@fda.hhs.gov.